Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.
Narita S, Kimura T, Hatakeyama S, Hata K, Yanagisawa T, Maita S, Chiba S, Sato H, Kashima S, Koizumi A, Yamamoto R, Takayama K, Okane K, Ishida T, Horikawa Y, Kumazawa T, Shimoda J, Suzuki T, Ohyama C, Egawa S, Habuchi T. Narita S, et al. Among authors: kumazawa t. Int J Clin Oncol. 2022 Sep;27(9):1477-1486. doi: 10.1007/s10147-022-02203-y. Epub 2022 Jun 24. Int J Clin Oncol. 2022. PMID: 35748967
Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study.
Numakura K, Kobayashi M, Ishida T, Okane K, Suzuki K, Shimoda N, Suzuki T, Kumazawa T, Sasaki R, Fukuda H, Kashima S, Yamamoto R, Koizumi A, Nara T, Kanda S, Huang M, Saito M, Narita S, Inoue T, Tsuchiya N, Habuchi T. Numakura K, et al. Among authors: kumazawa t. Eur Urol Focus. 2022 Nov;8(6):1666-1672. doi: 10.1016/j.euf.2022.06.002. Epub 2022 Jun 15. Eur Urol Focus. 2022. PMID: 35717522 Clinical Trial.
Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.
Narita S, Kimura T, Hatakeyama S, Hata K, Yanagisawa T, Maita S, Chiba S, Sato H, Kashima S, Koizumi A, Yamamoto R, Takayama K, Okane K, Ishida T, Horikawa Y, Kumazawa T, Shimoda J, Suzuki T, Ohyama C, Egawa S, Nomura K, Habuchi T. Narita S, et al. Among authors: kumazawa t. World J Urol. 2022 May;40(5):1135-1141. doi: 10.1007/s00345-022-03963-y. Epub 2022 Feb 26. World J Urol. 2022. PMID: 35218371
Ingestion of miso regulates immunological robustness in mice.
Kotake K, Kumazawa T, Nakamura K, Shimizu Y, Ayabe T, Adachi T. Kotake K, et al. Among authors: kumazawa t. PLoS One. 2022 Jan 21;17(1):e0261680. doi: 10.1371/journal.pone.0261680. eCollection 2022. PLoS One. 2022. PMID: 35061718 Free PMC article.
637 results